Skip to Content

Macugen (pegaptanib ophthalmic) Disease Interactions

There is 1 disease interaction with Macugen (pegaptanib ophthalmic):

Major

Intravitreal Injections (Includes Macugen) ↔ Ocular Infections

Severe Potential Hazard, High plausibility

Applies to: Ocular Infection, Uveitis, Orbital Infection, Infectious Endophthalmitis, Infectious Optic Neuritis

Intravitreal administration, including those with aflibercept, pegaptanib, and ranibizumab is contraindicated in patients with active intraocular inflammation or ocular/periocular infections, since endophthalmitis can occur following the use of these injections. Patients should be advised to seek immediate medical attention from an ophthalmologist if the eye becomes red, photosensitive or painful, or if there is a change in vision in the days following the injection.

Macugen (pegaptanib ophthalmic) drug Interactions

There are 2 drug interactions with Macugen (pegaptanib ophthalmic)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide